Hormos Nutraceutical Oy Ltd.
Records under this name other than patents Hormos Nutraceutical Oy Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Hormos Nutraceutical Oy Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,008,666 | Method of inhibiting overactivity of phagocytes or lymphocytes in an individual Term ended Term ended Nov 26, 2021 · USPTO record | Term ended | Term ended Nov 26, 2021 | USPTO record |
| US 7,005,447 | Food product comprising hydroxymatairesinol Term ended Term ended Feb 3, 2020 · USPTO record | Term ended | Term ended Feb 3, 2020 | USPTO record |
| US 6,689,809 | Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol Term ended Ended no later than Jul 9, 2019 · USPTO record | Term ended | Ended no later than Jul 9, 2019 | USPTO record |
| US 6,451,849 | Use of Hydroxymatairesinol for Prevention of Cancers, Non-Cancer, Hormone Dependent Diseases and Cardiovascular Diseases by Hydroxymatairesinol, and a Pharmaceutical Preparation, Food Additive and Food Product Comprising Hydroxymatairesinol Term ended Term ended Mar 30, 2019 · USPTO record | Term ended | Term ended Mar 30, 2019 | USPTO record |
| US 6,271,257 | Decreasing the intracellular level of .beta.-catenin by administering hydroxymatairesinol Lapsed on the fee record Ended Aug 7, 2013 · USPTO record | Lapsed on the fee record | Ended Aug 7, 2013 | USPTO record |